The Brain on GLP-1 Agonists
7 October 2024
9:00 AM - 10:00 AM CDT
Session Description
Millions of patients are now taking drugs like Ozempic, which target GLP-1 receptors to reduce appetite. But GLP-1 receptors are widespread in the brain, suggesting that these drugs may have off-target effects. Speakers will explain newly identified applications for GLP-1 drugs in Alzheimer's disease and for managing pain, as well as less desirable impacts on motivation.